CHEK2 and cancer: DNA damage is first recognized by molecular “sensors”, most notably those in the ATR/Chk1- and ATM/Chk2-mediated signalling pathways [54], which are hyperactivated in various cancers and associated with chemoresistance and poor prognosis [54–56].